BIOLIFE SOLUTIONS INC (BLFS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 50M 100M 150M FY10: 2.1M FY11: 2.8M FY12: 5.7M FY13: 8.9M FY14: 6.2M FY17: 11M FY18: 19.7M FY19: 27.4M FY20: 48.1M FY21: 119.2M FY22: 76.2M FY23: 68M FY24: 74.6M FY25: 96.2M FY11 FY13 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 25M 50M 75M FY10: 856.4K FY11: 1.4M FY12: 2.3M FY13: 3.8M FY14: 3M FY15: 3.8M FY16: 4.8M FY17: 6.7M FY18: 13.5M FY23: 41.3M FY24: 50.1M FY25: 62.1M FY11 FY13 FY15 FY17 FY23 FY25

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY10: -1.4M FY11: -1.2M FY12: -942.2K FY13: -285.4K FY14: -3.1M FY15: -5M FY16: -4.9M FY17: -1.1M FY18: 3.7M FY19: -220K FY20: -6.2M FY21: -35.2M FY22: -5.9M FY23: -17.2M FY24: -4.5M FY25: -16.6M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-150M -100M -50M 0 50M 100M 150M FY10: -2M FY11: -2M FY12: -1.7M FY13: -1.1M FY14: -3.2M FY15: -4.2M FY16: -6.9M FY17: -2.5M FY18: -25M FY19: -1.7M FY20: 2M FY21: -8.9M FY22: -139.8M FY23: -68M FY24: -20.2M FY25: -4.6M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 15M 30M 45M FY10: 1.2M FY11: 1.4M FY12: 3.4M FY13: 5.2M FY14: 3.2M FY15: 2.6M FY16: 3.4M FY17: 4.3M FY18: 6.2M FY19: 8.8M FY23: 26.7M FY24: 24.6M FY25: 34.1M FY10 FY12 FY14 FY16 FY18 FY23 FY25

Operating Cash Flow Annual

-14M -7M 0 7M 14M 21M FY10: -1.3M FY11: -989.9K FY12: 854.9K FY13: 146K FY14: -3.2M FY15: -5M FY16: -4.3M FY17: 605K FY18: 2.3M FY19: 1.2M FY20: 6.6M FY21: -4.6M FY22: -8.5M FY23: -12.5M FY24: 8.4M FY25: 20.1M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-21M -14M -7M 0 7M 14M 21M FY10: -1.3M FY11: -1.1M FY12: -296.8K FY13: -90.7K FY14: -3.8M FY15: -5.1M FY16: -4.5M FY17: 461K FY18: 1.8M FY19: 538K FY20: 4.7M FY21: -13M FY22: -18.9M FY23: -18.9M FY24: 5.2M FY25: 10.6M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 25M 50M 75M FY11: 69.7M FY12: 5M FY13: 5M FY17: 13.3M FY18: 21.6M FY19: 19.5M FY20: 27.3M FY21: 38.5M FY22: 43.1M FY23: 43.7M FY24: 46.1M FY25: 48.6M FY12 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '11: -0.04 Q3 '11: -0.04 Q4 '11: -0.04 Q1 '12: -0.03 Q2 '12: -0.03 Q3 '12: -0.03 Q4 '12: -0.33 Q1 '13: -0.33 Q2 '13: -0.38 Q3 '13: -0.43 Q4 '13: -0.22 Q1 '14: -0.32 Q2 '14: -0.33 Q3 '14: -0.34 Q4 '14: -0.32 Q1 '15: -0.31 Q2 '15: -0.32 Q3 '15: -0.34 Q4 '15: -0.35 Q1 '16: -0.36 Q2 '16: -0.39 Q3 '16: -0.38 Q4 '16: -0.55 Q1 '17: -0.52 Q2 '17: -0.47 Q3 '17: -0.42 Q4 '17: -0.21 Q1 '21: -0.84 Q2 '21: 0.05 Q3 '21: 0.09 Q4 '21: -0.24 Q1 '22: -0.39 Q2 '22: -2.30 Q3 '22: -2.54 Q4 '22: -3.25 Q1 '23: -3.39 Q2 '23: -1.90 Q3 '23: -2.33 Q4 '23: -1.55 Q1 '24: -1.45 Q2 '24: -1.67 Q3 '24: -1.04 Q4 '24: -0.44 Q1 '25: -0.22 Q2 '25: -0.10 Q3 '25: -0.05 Q1 '12 Q3 '13 Q1 '15 Q3 '16 Q1 '21 Q3 '22 Q1 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.